Multiplication stimulating activity (MSA) from the BRL 3A rat liver cell line: Relation to human somatomedins and insulin
Matthew M. Rechler(National Institutes of Health), Robert M. White(National Institutes of Health), Patricia A. Short(Brigham and Women's Hospital), Ellen Van Obberghen‐Schilling(Centre National de la Recherche Scientifique), Alan C. Moses(National Institutes of Health), S. Peter Nissley, George L. King(Joslin Diabetes Center), Alfred B. Knight(National Institutes of Health), Joyce A. Romanus(National Institutes of Health)
Journal of Supramolecular Structure and Cellular Biochemistry
January 1, 1981
Cited by 55
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979